en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2021
vol. 27
 
Share:
Share:
abstract:
Case report

To increase body height and muscle strength – one medicine for two diseases? Case report of a boy with Silver-Russell syndrome and Duchenne muscular dystrophy

Joanna A. Chrzanowska
1
,
Lidia Bubula
2
,
Anna Noczyńska
1
,
Agnieszka Zubkiewicz-Kucharska
1

  1. Department of Endocrinology and Diabetology of the Developmental Age, Medical University of Wroclaw, Poland
  2. Student Scientific Club at the Department of Endocrinology and Diabetology of the Developmental Age, Medical University of Wroclaw, Poland
Pediatr Endocrinol Diabetes Metab 2021; 27 (4): 298–304
Online publish date: 2021/12/14
View full text Get citation
 
PlumX metrics:
The coexistence of 2 genetic diseases can mutually modify their course. We describe the case of a 10-year-old boy with Sliver-Russell syndrome (SRS) and Duchenne muscular dystrophy (DMD). The patient's short stature, which is part of the clinical picture of both diseases, has been additionally aggravated by the steroid therapy, which is necessary to delay the progression of DMD. From the age of 9 years, the patient was treated with recombinant human growth hormone (rhGH) for 18 months. The following study discusses whether rhGH therapy in a child with SRS and DMD may alleviate or worsen the course of DMD, and how it affects carbohydrate metabolism disorders.
keywords:

growth hormone, Duchenne muscular dystrophy, Silver-Russell syndrome


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.